Ex-Alexion, bluebird execs launch VC and manufacturing firm with $150M
May 13, 2019 at 07:01 AM EDT
The former CEO of Alexion Pharmaceuticals and chief scientific officer at bluebird bio have raised $150 million to launch a new biotech investment and manufacturing firm for cell and gene therapies.
